Financial Performance - The company's operating revenue for 2021 was CNY 1,252,459,155.24, representing a 23.83% increase compared to CNY 1,011,418,016.27 in 2020[20]. - The net profit attributable to shareholders of the listed company for 2021 was CNY 165,657,630.46, a 21.15% increase from CNY 136,742,721.34 in 2020[20]. - The net profit attributable to shareholders after deducting non-recurring gains and losses increased by 42.45% to CNY 126,168,664.65 in 2021 from CNY 88,571,255.53 in 2020[22]. - The basic earnings per share for 2021 was CNY 1.53, up 24.39% from CNY 1.23 in 2020[21]. - The weighted average return on net assets increased to 6.24% in 2021, up from 5.12% in 2020, an increase of 1.12 percentage points[21]. - The company's cash flow from operating activities decreased by 61.75% to CNY 73,047,039.44 in 2021, compared to CNY 190,983,693.21 in 2020, primarily due to increased inventory purchases[22]. - The total assets of the company at the end of 2021 were CNY 3,862,740,277.63, a 16.94% increase from CNY 3,303,224,167.49 at the end of 2020[20]. - The company's total revenue for the reporting period reached ¥1,252,096,211.03, with a gross margin of 27.55%, an increase of 2.28 percentage points compared to the previous year[114]. - The export revenue amounted to ¥657,689,910.03, showing a year-on-year increase of 41.41%, driven by improved sales channels and recovering demand in international markets[116]. Dividend Distribution - The company plans to distribute a cash dividend of RMB 5.00 per 10 shares, totaling RMB 54,202,776.00, which represents 61.49% of the net profit attributable to shareholders for the year[5]. - As of March 31, 2022, the total share capital of the company is 111,226,800 shares, with 2,821,248 shares held in the repurchase account not participating in the dividend distribution[5]. Corporate Governance - The company has not reported any non-operating fund occupation by controlling shareholders or related parties[7]. - The company has not faced any violations in decision-making procedures for external guarantees[7]. - The company has not disclosed any special arrangements for corporate governance[7]. - The company emphasizes the importance of maintaining a robust governance structure to ensure compliance and effective decision-making[188]. - The company maintains strict independence from its controlling shareholder, with independent operations in business and finance, ensuring no fund misappropriation issues[190]. - The fourth board of directors consists of 9 members, including 3 independent directors, complying with legal requirements for governance[191]. - The fourth supervisory board is composed of 3 members, including 1 employee supervisor, ensuring compliance with legal standards[192]. - The company has established comprehensive management systems, including revised internal control and financial management regulations, enhancing governance[193]. - The company has implemented an information disclosure management system to ensure the accuracy and timeliness of disclosures, in line with regulatory requirements[194]. - There are no significant discrepancies between the company's governance practices and regulatory requirements, ensuring compliance[196]. Research and Development - The company has a strong R&D capability with numerous patents and a mature system for converting research results into products[38]. - The company achieved a total R&D investment of ¥70,763,679.66, representing a 35.71% increase compared to the previous year[66]. - R&D investment accounted for 5.65% of total revenue, an increase of 0.49 percentage points from the previous year[66]. - The company holds a total of 84 patents, including 64 invention patents and 20 utility model patents, reflecting strong R&D capabilities[79]. - The company has developed new production processes for photoinitiators, improving efficiency and reducing environmental impact[62]. - The company is focusing on developing new products and technologies, including UV LED photoinitiators suitable for light-colored inks[62]. - The company has established multiple research centers and received various innovation awards during the reporting period[63]. - The company is focusing on developing new photoinitiators and specialty UV curing materials, although it faces challenges in innovation and market demand fluctuations[87]. Market Position and Strategy - The company is the largest and most comprehensive supplier of photoinitiators in China, with a significant global influence in the UV curing field[37]. - The company is focusing on the core industry of photopolymerization and expanding into the semiconductor sector, aiming for global market development[30]. - The company is actively extending its photopolymerization industry chain and expanding into electronic chemical materials[30]. - The company is committed to enhancing its core competitiveness through independent innovation and technology development[32]. - The company has established a strategic direction centered on the photopolymerization industry and semiconductor industry, aiming for global market expansion[182]. - The company is positioned to benefit from favorable policies related to carbon reduction goals, enhancing the market penetration of its photoinitiator products[143]. Risks and Challenges - The company emphasizes the importance of risk factors in its operations, advising investors to pay attention to potential risks[4]. - The company faces risks from intensified industry competition and potential price declines, despite its stable product quality and customer loyalty[90]. - The company faces exchange rate risks due to a significant portion of its revenue coming from exports, which may be impacted by fluctuations in the RMB to USD exchange rate[91]. - The company is experiencing increased operational management pressure due to rapid growth and expansion, necessitating improvements in its management systems[89]. - The ongoing COVID-19 pandemic continues to pose risks to the company's export business, particularly in countries with poor pandemic control[99]. Investments and Acquisitions - The company acquired 40% of Hongrun Chemical's shares, increasing its stake to 52%, making it a controlling subsidiary[35]. - The company is expanding its semiconductor electronic chemical materials business through acquisitions, including Jinghong Bio and Keli Bio, and introducing strategic investors[34]. - The company plans to acquire 100% equity of Huaihua Taitong, with the acquisition process currently underway[168]. - The company has established a wholly-owned subsidiary, Jiuxing Zhihui, with a registered capital of RMB 10 million for environmental-friendly radiation curing coating projects[169]. - The company acquired 100% equity of Jinghong Biological for RMB 9 million, focusing on electronic chemical materials[169]. Production and Supply Chain - The company has developed new production processes for key products like 1173 and 184, significantly reducing raw material consumption and waste generation[148]. - The company has optimized production lines for its main products, achieving a continuous production process that minimizes hazardous chemical use and waste emissions[158]. - The company has established multiple modern production bases to ensure stable supply of core photoinitiators like 184, TPO, and DETX, enhancing its competitive advantage in the market[82]. - The company is focusing on optimizing its production processes to improve efficiency and reduce costs, while also addressing environmental concerns[184].

Financial Performance - The company's operating revenue for Q1 2022 was CNY 422,988,893.15, representing a year-on-year increase of 35.84%[4] - The net profit attributable to shareholders was CNY 54,775,456.06, reflecting a growth of 43.22% compared to the same period last year[4] - The net profit attributable to shareholders after deducting non-recurring gains and losses increased by 81.57% to CNY 47,604,110.91[4] - Basic and diluted earnings per share were both CNY 0.51, marking a 50.00% increase from the previous year[4] - Net profit for Q1 2022 was ¥60,206,842.13, up 57.5% from ¥38,218,112.15 in Q1 2021[20] - Operating profit for Q1 2022 was ¥73,406,666.63, representing a 59.1% increase compared to ¥46,135,361.21 in Q1 2021[20] - The company reported a total comprehensive income of ¥55,065,668.79 for Q1 2022, compared to ¥37,729,683.16 in Q1 2021[21] Cash Flow - The net cash flow from operating activities reached CNY 37,454,291.96, a significant increase of 1,018.99% year-on-year[4] - In Q1 2022, the cash inflow from operating activities was CNY 392,723,047.60, a 60% increase from CNY 245,289,422.04 in Q1 2021[23] - The net cash flow from operating activities reached CNY 37,454,291.96, compared to CNY 3,347,151.62 in the same period last year, indicating significant improvement[24] - The total cash outflow from investing activities was CNY 709,559,382.35, up from CNY 486,423,258.31 in Q1 2021, resulting in a net cash outflow of CNY 244,329,279.32[24] - The cash inflow from financing activities was CNY 254,143,747.32, compared to CNY 86,205,179.02 in Q1 2021, showing a substantial increase[24] Assets and Liabilities - Total assets at the end of the reporting period were CNY 4,093,240,885.23, up 5.97% from the end of the previous year[5] - The company's current assets totaled RMB 2,214,390,862.45, compared to RMB 2,082,661,951.33 at the end of 2021, indicating an increase of about 6.34%[17] - The total liabilities as of Q1 2022 amounted to ¥1,197,871,927.27, compared to ¥1,024,363,104.63 in Q1 2021, reflecting a 16.9% increase[19] - The company's total liabilities increased to CNY 514,067,191.69 from CNY 485,965,717.47 at the end of 2021[27] - The total equity decreased to CNY 2,576,076,531.22 from CNY 2,582,186,339.85 at the end of 2021[28] Research and Development - Research and development expenses amounted to CNY 21,208,575.74, accounting for 5.01% of operating revenue, a decrease of 0.46 percentage points[5] - Research and development expenses for Q1 2022 totaled ¥21,208,575.74, an increase from ¥17,031,304.12 in Q1 2021[19] - Research and development expenses increased to ¥5,092,449.04 in Q1 2022, up 37.8% from ¥3,696,077.63 in Q1 2021[30] Subsidiaries and Investments - The company’s subsidiary, Hunan Jiuri, contributed to revenue growth following the acquisition of Hongrun Chemical at the end of 2021[9] - The company’s subsidiary, Inner Mongolia Jiuri New Materials Co., Ltd., has commenced production for a new project with an annual capacity of 9,250 tons of photoinitiators and intermediates, which began trial operations on March 15, 2022[15] - The company reported a significant increase in trading financial assets, which rose to RMB 341,343,692.70 from RMB 100,290,000.00, indicating a growth of approximately 240.5%[16] - The company’s long-term equity investments increased slightly to RMB 122,947,518.86 from RMB 122,444,752.95, reflecting a growth of about 0.41%[17] - The company’s investment income for Q1 2022 was ¥4,174,626.19, a significant drop from ¥192,625,232.09 in Q1 2021[30]

2021 年第三季度报告 证券代码：688199 证券简称：久日新材 天津久日新材料股份有限公司 2021 年第三季度报告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或 者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 重要内容提示： 公司董事会、监事会及董事、监事、高级管理人员保证季度报告内容的真实、准确、完整， 不存在虚假记载、误导性陈述或重大遗漏，并承担个别和连带的法律责任。 一、 主要财务数据 (一)主要会计数据和财务指标 单位：元 币种：人民币 | 项目 | 本报告期 | 本报告期 比上年同 | 年初至报告期末 | 年初至报告期 末比上年同期 | | --- | --- | --- | --- | --- | | | | 期增减变 | | 增减变动幅度 | | | | 动幅度(%) | | (%) | | 营业收入 | 265,545,777.90 | 18.12 | 894,241,003.36 | 26.40 | | 归属于上市公司股东的 | 24,487,373.90 | -37.10 | 108,146,877.61 | -5.23 | | 净利润 | ...

Financial Performance - The company reported a significant increase in revenue, achieving a total of 1.5 billion RMB for the first half of 2021, representing a year-on-year growth of 25%[16] - The company's operating revenue increased by 30.26% year-on-year, reaching approximately RMB 628.70 million, driven by strategic price reductions and an expanded market share, with sales of photoinitiators growing by 56.58% compared to the same period last year[24] - Basic earnings per share rose to RMB 0.77, reflecting a 13.24% increase from RMB 0.68 in the same period last year[22] - The net profit attributable to shareholders was approximately RMB 83.66 million, an increase of 11.26% from RMB 75.19 million year-on-year[24] - The gross profit margin for the first half of 2021 was reported at 35%, an increase from 30% in the same period last year[16] - Investment income surged by 361.56% to ¥19,499,392.70, attributed to increased interest income from held financial instruments[100] - Operating costs rose by 31.49% to ¥470,733,404.30, primarily due to increased revenue and the inclusion of transportation costs[102] - Cash flow from operating activities decreased by 27.28% to approximately RMB 69.33 million compared to RMB 95.34 million in the previous year[24] Market Expansion and Strategy - The company provided a positive outlook for the second half of 2021, projecting a revenue growth of 20% to 30% based on current market trends and demand[16] - The company is expanding its market presence in Southeast Asia, targeting a 10% market share in the region by the end of 2022[16] - A strategic acquisition of a local competitor is in progress, which is anticipated to enhance production capacity by 30% and reduce operational costs by 15%[16] - The company plans to continue expanding its product offerings and market presence in the photoinitiator sector, capitalizing on the growing demand for UV curing technology[29] - The company is focusing on expanding its market presence through strategic investments and new product development in the photoinitiator sector[119] Research and Development - The company has invested 100 million RMB in R&D for new technologies aimed at improving product efficiency and sustainability[16] - Research and development expenses accounted for 5.37% of operating revenue, up from 3.59% in the previous year, indicating a focus on innovation[22] - The company achieved a total R&D investment of ¥33,780,917.25, representing a 94.96% increase compared to ¥17,327,487.67 in the previous period[52] - The company holds 61 invention patents and 8 utility model patents, indicating strong innovation capabilities in photoinitiator technology[32] - The company has developed new production processes for light curing agents, significantly reducing the use of hazardous materials and improving environmental safety[49] Environmental Compliance and Sustainability - The company has invested significantly in environmental protection facilities and technology improvements to comply with environmental regulations, which may increase operational costs if stricter laws are implemented in the future[85] - The company has implemented measures to reduce carbon emissions by optimizing production processes and recovering heat from steam waste[146] - Pollution prevention measures include clean production practices and the implementation of rainwater and sewage separation systems[130] - The company has established a comprehensive monitoring program to ensure compliance with environmental regulations and maintain operational transparency[138] - All subsidiaries complied with national and local environmental laws, achieving emissions that meet relevant standards without facing penalties[129] Risks and Challenges - The company faces risks related to market competition, technological changes, and potential fluctuations in tax policies affecting profitability[80][83] - The ongoing COVID-19 pandemic continues to pose risks to the company's export business, particularly in countries with poor pandemic control, potentially affecting demand[93] - The company is at risk of losing core technical personnel due to intensified competition for talent, which could adversely affect its operational performance and long-term development[88] - The company faces potential risks from price fluctuations in the photoinitiator manufacturing industry due to increased competition and external uncertainties caused by the COVID-19 pandemic, leading to pressure on product prices[86] Corporate Governance and Shareholder Relations - The company is committed to adhering to any changes in laws and regulations regarding shareholding and transfer during the holding period[159] - The company will implement a sustainable and stable profit distribution policy, considering the opinions of investors, especially minority shareholders[190] - The company has confirmed that its application documents for the IPO do not contain any false records or significant omissions, taking collective legal responsibility[195] - The company will publicly apologize and compensate investors for any failure to fulfill compensation measures as determined by regulatory authorities[184] - The company commits to minimizing investor losses and will explore solutions to protect investor interests[199]

Financial Performance - The company's operating revenue for 2020 was ¥1,011,418,016.27, a decrease of 24.23% compared to ¥1,334,866,139.24 in 2019[22]. - The net profit attributable to shareholders decreased by 45.01% to ¥136,742,721.34 from ¥248,687,778.77 in the previous year[22]. - The basic earnings per share fell by 56.84% to ¥1.23, down from ¥2.85 in 2019[23]. - The cash flow from operating activities increased by 24.09% to ¥190,983,693.21 compared to ¥153,901,917.19 in 2019[22]. - The company's total assets rose by 11.08% to ¥3,303,224,167.49 at the end of 2020, up from ¥2,973,634,427.79 in 2019[22]. - The net profit attributable to shareholders after deducting non-recurring gains and losses decreased by 63.18% to ¥88,571,255.53[22]. - The weighted average return on equity decreased by 16.48 percentage points to 5.12% from 21.60% in 2019[23]. - The company reported a total of ¥48,171,465.81 in non-recurring gains for 2020, compared to ¥8,138,918.35 in 2019[27]. - The company reported a significant decrease in trading financial assets, with a decline of approximately 55.6% from CNY 1,355,211,447.30 to CNY 601,975,347.03, impacting profits by CNY 30,814,638.32[29]. Research and Development - Research and development expenses accounted for 5.16% of operating revenue, an increase from 4.97% in 2019[23]. - The company applied for 18 new patents during the reporting period, including 13 invention patents and 5 utility model patents[52]. - A total of 52,141,736.74 yuan was invested in research and development, representing a decrease of 21.42% compared to the previous year[55]. - The proportion of total R&D investment to operating income increased to 5.16%, up from 4.97% in the previous year[55]. - The company has developed new products such as macromolecular photoinitiators and low-odor photoinitiators, enhancing its competitive edge in meeting customer needs[46]. - The company’s core technologies are focused on improving process technology to enhance yield and product quality while reducing costs and emissions[49]. - The company has developed a new production process for the TPO light initiator, which simplifies production and reduces the use of hazardous materials[50]. - The company has made significant advancements in the development of low-chlorine light initiators and high-efficiency large molecule TX-type light initiators[51]. Market Position and Strategy - The company is the largest producer of photoinitiators in China, with a comprehensive product range and global influence in the UV curing field[31]. - The company aims to leverage policy support for energy-saving and emission-reduction technologies to increase market penetration of photoinitiators[31]. - The photoinitiator products are widely used in various industries, including wood coatings, plastic coatings, and 3D printing, driven by increasing environmental regulations and market demand[39]. - The company has established a strategic layout in the semiconductor materials field by acquiring Dajing New Materials and Dajing Information, focusing on the industrialization of photoinitiators[84]. - The company is expanding its production capacity with new projects, including an annual production of 9,250 tons of photoinitiators in Inner Mongolia and 87,000 tons of photoinitiators in Dongying[83][84]. - The company emphasizes long-term, stable relationships with high-quality customers, which enhances its competitive edge in the photoinitiator market[75]. - The company is committed to developing new photoinitiators and specialty photopolymer materials, but faces risks related to technological innovation and market demand changes[88]. - The company is actively expanding its market presence through strategic investments and partnerships in the new materials sector[178]. Dividend Policy - The company plans to distribute a cash dividend of RMB 3.50 per 10 shares (including tax) to all shareholders based on the total share capital minus the shares held in the repurchase account[5]. - The total cash dividend amount for 2020 was RMB 79,993,245.34, representing 58.50% of the profits available for distribution[193]. - The cash dividend for the year 2020 accounts for 27.75% of the net profit attributable to shareholders of the listed company in the consolidated financial statements[191]. - The company has maintained a consistent dividend policy over the past three years, with cash dividends of RMB 3.50 in 2020, RMB 10.00 in 2019, and RMB 15.00 in 2018[191]. - The independent directors provided clear consent regarding the dividend distribution proposal, ensuring the protection of minority shareholders' rights[190]. Operational Challenges - The company is experiencing increased operational management challenges due to rapid growth in business scale and employee numbers, necessitating improvements in management systems[89]. - The company is facing risks related to the implementation of fundraising investment projects, particularly concerning land acquisition for the construction of a new facility in Dongying, Shandong[99]. - The construction project for producing 87,000 tons of light-curing materials is currently delayed due to land issues, with only partial work being conducted[100]. - The company is actively monitoring the impact of the COVID-19 pandemic on downstream demand, particularly for its export business[98]. - The company has identified risks of continued decline in gross margin due to competitive pricing strategies adopted in response to market conditions[101]. Corporate Governance - The company has received a standard unqualified audit report from Dahua Certified Public Accountants[5]. - The company emphasizes that the forward-looking statements in the report do not constitute a substantive commitment to investors, highlighting potential investment risks[6]. - The company has confirmed that there are no non-operating fund occupations by controlling shareholders and their related parties[7]. - The company has not violated decision-making procedures for providing guarantees[7]. - The company has reported that all board members can guarantee the authenticity, accuracy, and completeness of the annual report[7]. Production and Supply Chain - The company has established three modern production bases in Shandong, Jiangsu, and Hunan, with plans for three additional bases in Inner Mongolia, Jiangsu, and Shandong[37]. - The company employs a "sales-driven production" model, aligning production plans with customer orders and market trends to ensure product availability[37]. - The company has a centralized procurement model, ensuring efficient management of raw materials based on sales forecasts and production plans[36]. - The company has established modern production bases to ensure stable supply and safety for downstream customers[44]. Environmental and Regulatory Compliance - The company focuses on the research and development of environmentally friendly, energy-efficient, and high-performance photoinitiators, contributing to air pollution prevention and industrial upgrades[150]. - The company has invested heavily in environmental protection measures, but faces potential regulatory changes that could increase operational costs[93]. - The company’s products are essential for achieving national VOCs reduction strategies and carbon neutrality goals[149].

Financial Performance - In 2020, the company's operating revenue was approximately CNY 1.01 billion, a decrease of 24.23% compared to CNY 1.33 billion in 2019[22]. - The net profit attributable to shareholders decreased by 45.01% to CNY 136.74 million from CNY 248.69 million in 2019[24]. - The basic earnings per share fell by 56.84% to CNY 1.23, down from CNY 2.85 in the previous year[23]. - The company reported a net cash flow from operating activities of CNY 190.98 million, an increase of 24.09% compared to CNY 153.90 million in 2019[22]. - The total assets increased by 11.08% to CNY 3.30 billion from CNY 2.97 billion in 2019[22]. - The fourth quarter revenue was CNY 303.97 million, showing a recovery trend compared to earlier quarters[28]. - The company achieved an operating income of ¥1,011,418,016.27, a year-on-year decrease of 24.23%, and a net profit attributable to shareholders of ¥136,742,721.34, down 45.01% year-on-year[78]. - The gross profit margin for the main business was 25.27%, down by 12.17 percentage points compared to the previous year[145]. Research and Development - The company has a strong R&D capability, with numerous patents and a mature system for technology transfer, focusing on environmentally friendly and energy-efficient products[32]. - The company holds 53 invention patents and 8 utility model patents, indicating strong R&D capabilities and innovation in photoinitiator technology[43]. - The total R&D investment amounted to ¥52,141,736.74, a decrease of 21.42% compared to the previous year[57]. - The number of R&D personnel has increased to 192, accounting for 19.12% of the total workforce, up from 16.43% in the previous period[64]. - The company has established a "National Enterprise Technology Center" and a "Tianjin Photoinitiator Technology Engineering Center" to enhance its R&D capabilities[67]. - The company is committed to enhancing its research and development capabilities, particularly in photopolymerization products and electronic chemical materials, to meet diverse customer needs[161]. Market Position and Strategy - The company is the largest and most comprehensive supplier of photoinitiators in China, with a significant global influence in the UV curing field[31]. - The photoinitiator market in China is experiencing stable growth, with significant potential for application expansion compared to developed countries[40]. - The company is transitioning from a conventional photoinitiator manufacturer to a solution provider for UV curing technology, enhancing its market competitiveness[48]. - The company has established long-term, stable relationships with high-quality customers, which enhances its competitive edge in the photoinitiator market[72]. - The company aims to enhance its market position in the light curing industry by diversifying its product line and expanding into new materials, particularly special monomers and resins[159]. Corporate Governance and Compliance - The company has received a standard unqualified audit report from Dahua Certified Public Accountants[5]. - The company does not face any non-operating fund occupation by controlling shareholders or related parties[7]. - The company has not violated decision-making procedures for external guarantees[7]. - The company has a comprehensive decision-making mechanism for profit distribution, ensuring transparency and compliance with regulations to protect minority shareholders' rights[168]. - The company has commitments from major shareholders and management regarding shareholding restrictions and stock price stabilization measures[173]. Risks and Challenges - The company is facing risks related to core competitiveness, as market demand and technological advancements continue to evolve, potentially impacting its market position[85]. - The company is exposed to macroeconomic risks, including exchange rate fluctuations that could affect its export revenues and profits[88]. - The company is experiencing price pressure on its products due to intensified competition and external factors such as the COVID-19 pandemic, leading to a decline in product prices[91]. - The company faces potential risks related to safety production due to the use of hazardous chemicals and processes, which could lead to accidents and regulatory penalties[90]. - Rising labor costs are a concern as the company expands its workforce and increases employee salaries, which may not align with revenue growth[92]. Shareholder Returns - The company plans to distribute a cash dividend of RMB 3.50 per 10 shares to all shareholders, subject to approval at the shareholders' meeting[5]. - The cash dividend proposal for 2020 is to distribute RMB 3.50 per 10 shares (including tax), amounting to a total cash dividend of approximately RMB 37.94 million, which represents 27.75% of the net profit attributable to shareholders[169]. - The company has not proposed a cash profit distribution plan for the reporting period despite having positive distributable profits[172]. - The company repurchased shares amounting to 79,993,245.34 CNY in 2020, representing 58.50% of the cash dividend[172]. Production and Operations - The company operates three modern production bases in Shandong, Jiangsu, and Hunan, with plans for three additional bases to ensure stable product supply[37]. - The production model is based on "sales-driven production," aligning production plans with customer orders and market trends[37]. - The company has developed new production processes for its core products, such as 1173 and 184, which significantly reduce raw material consumption and waste generation, achieving nearly zero wastewater discharge[133]. - The company is expanding its production capacity with 6,200 tons under construction in Inner Mongolia, expected to be completed by December 2021[141].

2021 年第一季度报告 公司代码：688199 公司简称：久日新材 天津久日新材料股份有限公司 2021 年第一季度报告 1 / 21 | 一、 | 重要提示 3 | | --- | --- | | 二、 | 公司基本情况 3 | | 三、 | 重要事项 6 | | 四、 | 附录 10 | 2021 年第一季度报告 一、 重要提示 二、 公司基本情况 | | | 3 / 21 单位：元 币种：人民币 本报告期末 上年度末 本报告期末比上年度 末增减(%) 总资产 3,282,095,887.52 3,303,224,167.49 -0.64 归属于上市公司股 东的净资产 2,608,009,763.02 2,616,701,607.95 -0.33 年初至报告期末 上年初至上年报告期末 比上年同期增减(%) 经营活动产生的现 金流量净额 3,347,151.62 52,880,520.92 -93.67 年初至报告期末 上年初至上年报告期末 比上年同期增减（%） 营业收入 311,387,971.99 237,519,917.68 31.10 归属于上市公司股 东的净利润 38,244,937.96 22 ...

2020 年第三季度报告 公司代码：688199 公司简称：久日新材 天津久日新材料股份有限公司 2020 年第三季度报告 1 / 28 | 目录 | | --- | | 一、 | 重要提示 | 3 | | --- | --- | --- | | 二、 | 公司基本情况 | 3 | | 三、 | 重要事项 | 7 | | 四、 | 附录 | 11 | 2020 年第三季度报告 一、 重要提示 2020 年第三季度报告 非经常性损益项目和金额 1.1 公司董事会、监事会及董事、监事、高级管理人员保证季度报告内容的真实、准确、完整， 不存在虚假记载、误导性陈述或者重大遗漏，并承担个别和连带的法律责任。 1.2 公司全体董事出席董事会审议季度报告。 1.3 公司负责人赵国锋、主管会计工作负责人马秀玲及会计机构负责人（会计主管人员）马秀玲 保证季度报告中财务报表的真实、准确、完整。 1.4 本公司第三季度报告未经审计。 二、 公司基本情况 2.1 主要财务数据 3 / 28 单位：元 币种：人民币 本报告期末 上年度末 本报告期末比上年度 末增减(%) 总资产 3,181,915,878.65 2,973,634,4 ...

Financial Performance - The company's operating revenue for the first half of 2020 was ¥482,639,508.26, a decrease of 38.82% compared to ¥788,922,755.56 in the same period last year[18]. - The net profit attributable to shareholders for the first half of 2020 was ¥75,189,799.35, down 58.51% from ¥181,234,063.40 in the previous year[18]. - The basic earnings per share for the first half of 2020 was ¥0.68, a decrease of 69.23% from ¥2.21 in the same period last year[19]. - The net profit after deducting non-recurring gains and losses was ¥54,219,314.15, a decrease of 69.84% from ¥179,778,683.92 in the same period last year[18]. - Net profit attributable to shareholders decreased by 58.51% year-on-year, primarily due to a decrease in operating revenue[20]. - Basic and diluted earnings per share decreased by 69.23% year-on-year, reflecting the decline in net profit attributable to shareholders[20]. - Operating revenue decreased by 38.82% to ¥482,639,508.26 compared to ¥788,922,755.56 in the same period last year[91]. - Operating costs fell by 22.92% to ¥358,000,300.10 from ¥464,458,816.41 year-on-year[91]. Cash Flow and Investments - The net cash flow from operating activities increased by 122.58% to ¥95,338,608.76, compared to ¥42,833,423.23 in the same period last year[18]. - Cash and cash equivalents rose significantly by 708.64% to ¥786,843,698.41 from ¥97,304,095.98 year-on-year, primarily due to funds raised from the issuance of shares[97]. - The company reported a net cash inflow from investment activities of ¥450,954,031.39, a significant recovery from a net outflow of ¥57,846,797.10 in the previous year[92]. - The company's long-term equity investments increased by 615.97% to ¥13,821,982.53 from ¥1,930,521.41 in the same period last year[97]. - The company’s total liabilities decreased by 13.38% to ¥211,130,163.89 from ¥243,749,269.03 year-on-year[98]. Research and Development - Research and development expenses accounted for 3.59% of operating revenue, down 0.77 percentage points from 4.36% in the previous year[19]. - The total R&D investment for the period was approximately ¥17.33 million, accounting for 3.59% of the total revenue[51]. - The company has been committed to R&D innovation for over a decade, accumulating numerous patents and establishing a strong R&D capability[27]. - The company has developed over ten types of photoinitiators, including 184, TPO, 1173, and 907, and holds 52 patents, with 45 being invention patents[41]. - The company is focusing on expanding UV printing ink applications and improving product performance in various fields[53]. Market Position and Strategy - The company is the largest and most comprehensive supplier of photoinitiators in China, holding approximately 30% market share in the photoinitiator business[26]. - The company’s revenue model primarily relies on the sales of photoinitiator products and the margin between sales revenue and cost[30]. - The company is actively exploring new technologies and products, including UV LED technology and water-based UV curing materials, which are anticipated to expand market applications and reduce costs[44]. - The company is transitioning from a product-focused approach to providing comprehensive solutions, enhancing its influence and business stickiness with customers[65]. - The company is facing challenges in maintaining its competitive edge due to rapid market changes and increasing competition, necessitating ongoing innovation and adaptation[73]. Legal and Compliance Issues - The company is currently involved in a legal dispute with Caffaro, with potential liabilities amounting to approximately ¥48.98 million, which could impact financial performance[88]. - The company is involved in a legal dispute with Caffaro, claiming damages of €4.5961 million due to a breach of contract[151]. - Caffaro counterclaims for €6.0094 million, asserting that the company breached the contract first[152]. - The court ruled that both parties violated contractual obligations, leading to a dismissal of claims from both sides[152]. Environmental Responsibility - The company strictly adheres to national environmental protection laws and regulations, ensuring all pollutants are discharged according to relevant standards without penalties from environmental authorities[172]. - The company has achieved compliance in all monitored emission points, including VOCs and other hazardous substances[174]. - The company has not faced any penalties from environmental protection departments during the reporting period[173]. - The company is committed to ongoing improvements in pollution control and environmental management practices[172]. - All air pollution control facilities at Shandong Jiuri are operating normally and meeting standards, including 10 exhaust gas treatment systems with a 20m discharge stack[176]. Shareholder and Governance Matters - The company has committed to not transferring or entrusting the management of shares held prior to the IPO for a period of 36 months from the date of listing[115]. - The company will ensure that any share reduction does not violate previously made commitments[118]. - The company will adhere to legal regulations to continuously improve its governance structure, ensuring that shareholders can fully exercise their rights[137]. - The company has outlined specific penalties for non-compliance with the stock buyback obligations[131]. - The company will publicly disclose reasons for not implementing stabilization measures if conditions are not met[128].

2020 年第一季度报告 公司代码：688199 公司简称：久日新材 天津久日新材料股份有限公司 2020 年第一季度报告 1 / 25 | 一、 | 重要提示 3 | | --- | --- | | 二、 | 公司基本情况 3 | | 三、 | 重要事项 6 | | 四、 | 附录 10 | 2020 年第一季度报告 一、 重要提示 二、 公司基本情况 2.1 主要财务数据 | | 本报告期末 | 上年度末 | 本报告期末比上年度 末增减(%) | | --- | --- | --- | --- | | 总资产 | 3,018,072,259.17 | 2,973,634,427.79 | 1.49 | | 归属于上市公司股 | 2,693,797,291.42 | 2,667,259,789.70 | 0.99 | | 东的净资产 | | | | | | 年初至报告期末 | 上年初至上年报告期末 | 比上年同期增减(%) | | 经营活动产生的现 | 52,880,520.92 | 11,957,112.26 | 342.25 | | 金流量净额 | | | | | | 年初至报告期末 | 上年初至上年报 ...